市場調査レポート

一次細胞・幹細胞由来細胞市場:現在および将来の機会

The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities

発行 BioInformatics, LLC 商品コード 270379
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
一次細胞・幹細胞由来細胞市場:現在および将来の機会 The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities
出版日: 2013年05月17日 ページ情報: 英文
概要

当レポートでは、生命科学者を対象に実施したオンラインアンケート調査結果に基づき、現在研究で幹細胞を利用している、または計画中の研究者数、一次細胞を購入する研究者/ラボの割合、一次細胞購入関連の年間ラボ予算、収益に関する市場規模とサプライヤーのシェア、および収益に関する市場成長など分析しており、概略下記の構成でお届けいたします。

第1章 調査結果の分析と解釈

  • 一次細胞の利用
  • 研究に用いられる細胞の種類
  • 将来の一次細胞の計画
  • 分化またはECS由来の前駆細胞利用の評価計画
  • 哺乳類細胞培養の実施割合:細胞種類別
  • 最もよく用いられる一次細胞の種類
  • 細胞が用いられている動物の種類
  • 現在研究で用いられている正常一次細胞の種類
  • 一次細胞由来の病変組織の種類
  • 成人幹細胞を含む一次細胞種類のソース:分離およびラボでの確立、同業者からの獲得または商業サプライヤーからの購入
  • 一次細胞サプライヤーの経験
  • 商業サプライヤーから購入しない理由
  • 商業サプライヤーからの購入理由
  • 一次細胞の購入形式
  • 一次細胞培養に使用される媒体の平均リットル数/一月あたり
  • 今後12ヶ月間で商業サプライヤーからの一次細胞利用が変化する可能性
  • 利用する一次細胞ブランド
  • 最もよく利用する一次細胞ブランド、ほか

第2章 調査手法&人口統計

第3章 付録

目次
Product Code: 13-004

With barriers to entry low, the number of companies supplying high quality human tissue for research continues to rise. At the same time, the range of cell types available has also expanded to include more specialized normal cell types as well as cells isolated from non-normal or disease-state tissues. Many primary cell suppliers have also commercialized various types of multipotent stem cells, also called adult stem cells. Like other primary cells, adult stem cells have a fi nite number of population doublings in vitro. Depending on the cell type used, primary cells and adult stem cells are used in a wide variety of research applications: from basic or discovery research, to drug discovery and development; from ADME/Toxicology screening to regenerative medicine and in vitro tissue models.

In The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities, BioInformatics LLC takes the pulse of this dynamic market. This study seeks to identify where primary cells and primary cell suppliers fi t in the universe of cells used in in vitro systems, whether or not the use of primary cells is increasing or decreasing, what cell types are used most often, how satisfi ed scientists are with commercially available primary cells, and what is the market size and anticipated growth rate.

Stem Cell-Derived Differentiated Cells

Pluripotent stem cells-those capable of differentiating into any cell type-have captured the imagination of scientists across many disciplines. As cell culture know-how has evolved, better and more reproducible conditions for maintaining these cells in their pluripotent state have been developed. Concomitant with optimizing cell culture conditions to maintain pluripotency have been efforts to optimize the in vitro environment to induce differentiation to create populations of highly pure and rigorously characterized differentiated cell types, including neurons, cardiomyocytes and hepatocytes.

Because terminally differentiated cells can be used in many applications where primary cells are currently employed and because the concept is relatively new, suppliers are asking multiple questions about this technology. Are researchers responding to the availability of this new source of cells? How many? What cell types are important? Where are they obtained? How will the use of primary cells be affected by the availability of stem cell-derived differentiated cell types? The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities profi les this emerging market and the role of commercial suppliers in this area.

STUDY OBJECTIVES

This study of the academic and pharma/biotech sectors in North America and Europe will provide an analysis of the market for primary cells and an assessment of the brand equity for the leading companies who serve this market. This report will also describe the emerging market for stem cell-derived differentiated cells-a potential threat (or opportunity) for this market.

OBJECTIVES:

This study will explore the following market analytics:

  • The number of researchers who currently or plan to use primary cells in their research
  • Proportion of researchers/labs who purchase primary cells
  • Annual lab budget associated with primary cell purchase
  • Market size, in terms of revenue, based on 2012
  • Supplier share in terms of revenue
  • Market growth in terms of revenue in the next 12 months (through 2013)

This study will explore the following product analytics:

  • The different types of cells used in life science research
  • Motivation for primary cell use
  • The motivation for-or barriers preventing-the purchase of primary cells
  • The top primary cell types used
  • The leading suppliers of primary cells
  • Customer satisfaction with primary cell product offerings
  • The emerging commercial market for stem cell-derived differentiated cells by customer type, motivation for use, cell types, leading suppliers, and estimated budget

This study will explore the following brand analytics:

  • The Brand Share Index for leading primary cell suppliers
  • Customer loyalty and likelihood to reorder

METHODOLOGY

image1

The Market for Primary Cells & Stem-Cell Derived Cells: Current and Future Opportunities, is based on responses to a 43-question online survey for life scientists conducted by BioInformatics, LLC (Arlington, Virginia, USA). 894 life scientists participated in the survey between March 20 and April 9, 2013.

The electronic questionnaire was fi elded to registered members of The Science Advisory Board®. BioInformatics sponsors The Science Advisory Board, an online community of over 72,000 scientists, physicians and healthcare professionals from around the world.

The Science Advisory Board is divided into two panels Research and Clinical) and "convenes" regularly via Internet (scienceboard.net) to voice their opinions on a wide variety of issues relating to biomedical research and clinical technologies. These experts - representing all aspects of the life sciences and medicine - have agreed to make themselves available to participate in our online research activities. The Science Advisory Board members who participated in this study were drawn from the Board's Research Panel.


DEMOGRAPHICS

image2

image3

KEY FINDINGS

image4

image5

WHY CHOOSE OUR REPORTS?

Sources of Independent, Unbiased Research

Unlike reports from other firms that are based on an analyst's subjective summary of information from publicly available sources, our reports are based on the results of detailed surveys of hundreds - even thousands - of scientific and medical professionals who buy your products.

Developed by a Team of Experts

Our questionnaires are developed by a multi-disciplinary team of scientists, industry veterans and market research experts with years of experience. These professionals understand that survey questions need to be asked in a way that ensures the answers will directly address the business challenges you face. Once the survey data is collected, this same team creates a unique report that presents the reader with a thorough understanding of the topic and the scientific and business implications of the results based on sophisticated statistical analytics.

Custom Analysis & Research Available

If you'd like to delve deeper into the data from a study, we can always perform custom cross-tabulations or other analysis on your behalf. We can even pose follow-up questions to respondents who answered in a particular way or conduct a custom study to extend your knowledge.

Carefully Selected Survey Participants

When others promote results from their online surveys, they fail to mention the uncontrolled nature of their broadcast email invitations. To provide you with the most valid and accurate results possible, the respondents to our surveys are members of our unique online panel - The Science Advisory Board®. - which consists of almost 72,000 verified life science and biomedical professionals who have agreed to take part in our surveys, focus groups and other market research activities. These respondents are carefully selected based on their professional qualifications, market segments and geographic regions - we can even select them based on the products they use and their preferred suppliers.

Complimentary Consulting Provided

With your purchase, we offer one free hour of consultation with our talented team of scientific and business analysts who created the report. During this consultation, we can answer any questions you may have about the survey results and what we believe to be the significant trends affecting the market.

Table of Contents

REPORT HIGHLIGHTS

Section 1: Analysis and Interpretation of SurveyResults

  • Primary Cell Usage
  • Types of cells used in research
  • Future plans to use primary cells
  • Plans to evaluate the use of differentiated or progenitor cells derived from ECSs
  • Percentage of mammalian cell culture performed by cell type
  • Type of research for which primary cells are most often used
  • Types of animal species from which cells are used
  • Types of normal primary cells currently used in research
  • Types of diseased tissue from which primary cells are derived
  • Sources of primary cell types-including adult stem cells: isolated and established in the lab, obtained from a colleague or purchased from a commercial supplier
  • Experience with Primary Cell Suppliers
  • Reasons NOT purchased from a commercial supplier
  • Reasons purchases were made from commercial suppliers
  • Format in which cells are purchased
  • Average liters of medias used to culture primary cells per month
  • Expected change in use of primary cells from commercial suppliers over 12 months
  • Primary cell BRAND used
  • Primary cell BRAND used most often
  • Percentage of cultures grown using cell-specific medium from same brand from whom primary cell was purchased
  • Brand Experience with Primary Cell Suppliers
  • Satisfaction with primary cells by brand and by feature
  • Overall satisfaction with primary cells by brand
  • Likelihood to repurchase from same brand
  • Likelihood to recommend preferred brand
  • Familiarity with brands
  • Satisfaction with performance by brand
  • Acceptability of pricing by brand
  • Ease of purchase by brand
  • Helpfulness of customer service and technical support by brand
  • Lab Budgets for Primary Cells
  • Lab's budget for primary cells and media to culture primary cells in 2012 and projected 2013
  • Percentage of 2012 budget for primary cells and media spent by brand
  • Stem-Cell Derived Differentiated Cells
  • Length of time stem cell-derived differentiated cells have been used
  • Type of research where stem cell-derived differentiated cells are most often used
  • Reason to use/plan-to-use stem cell-derived differentiated cells
  • Animal species from which differentiated cells are derived
  • Types of stem cell-derived differentiated cell types used/plan-to-use
  • Average number of liters of media used to culture stem cell-derived differentiated cells
  • Expected changes in use of stem cell-derived differentiated cells
  • Sources for differentiated stem cell-derived cell types: the lab, from colleagues or from commercial suppliers
  • Brands of stem cell-derived differentiated cell products used
  • Format stem cell-derived differentiated cells are purchased in
  • 2012 and 2013 (projected) lab budgets for stem cell-derived differentiated cells and media to culture these cells

Section 2: Methodology & Demographics

  • Methodology - Questionnaire Overview
  • Methodology - Questionnaire Design
  • Demographics
  • Questionnaire

Section 3: Appendices

  • Appendix A: Additional Insights
  • Appendix B: Other Publications
  • Appendix C: About BioInformatics, LLC
  • Appendix D: Our Valued Clients
Back to Top